-
2
-
-
0348109419
-
Obesity, sleep apnea, and hypertension
-
Wolk R, Shamsuzzaman AS, Somers VK. Obesity, sleep apnea, and hypertension. Hypertension. 2003;42(6):1067-1074.
-
(2003)
Hypertension
, vol.42
, Issue.6
, pp. 1067-1074
-
-
Wolk, R.1
Shamsuzzaman, A.S.2
Somers, V.K.3
-
3
-
-
57749097799
-
Sleep and cardiovascular disease: An overview
-
Malhotra A, Loscalzo J. Sleep and cardiovascular disease: an overview. Prog Cardiovasc Dis. 2009;51(4):279-284.
-
(2009)
Prog Cardiovasc Dis
, vol.51
, Issue.4
, pp. 279-284
-
-
Malhotra, A.1
Loscalzo, J.2
-
4
-
-
33645517268
-
Inflammatory biomarkers in acute coronary syndromes: Part IV: Matrix metalloproteinases and biomarkers of platelet activation
-
Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory biomarkers in acute coronary syndromes: part IV: matrix metalloproteinases and biomarkers of platelet activation. Circulation. 2006;113(9):e382-e385.
-
(2006)
Circulation
, vol.113
, Issue.9
-
-
Armstrong, E.J.1
Morrow, D.A.2
Sabatine, M.S.3
-
5
-
-
33645305456
-
Inflammatory biomarkers in acute coronary syndromes: Part III: Biomarkers of oxidative stress and angiogenic growth factors
-
Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory biomarkers in acute coronary syndromes: part III: biomarkers of oxidative stress and angiogenic growth factors. Circulation. 2006;113(8):e289-e292.
-
(2006)
Circulation
, vol.113
, Issue.8
-
-
Armstrong, E.J.1
Morrow, D.A.2
Sabatine, M.S.3
-
6
-
-
33645085317
-
Inflammatory biomarkers in acute coronary syndromes - Part II: Acute-phase reactants and biomarkers of endothelial cell activation
-
DOI 10.1161/CIRCULATIONAHA.105.595538, PII 0000301720060221000022
-
Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory biomarkers in acute coronary syndromes: part II: acute-phase reactants and biomarkers of endothelial cell activation. Circulation. 2006;113(7):e152-e155. (Pubitemid 43879455)
-
(2006)
Circulation
, vol.113
, Issue.7
-
-
Armstrong, E.J.1
Morrow, D.A.2
Sabatine, M.S.3
-
7
-
-
33644868471
-
Inflammatory biomarkers in acute coronary syndromes: Part I: Introduction and cytokines
-
Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory biomarkers in acute coronary syndromes: part I: introduction and cytokines. Circulation. 2006;113(6):e72-e75.
-
(2006)
Circulation
, vol.113
, Issue.6
-
-
Armstrong, E.J.1
Morrow, D.A.2
Sabatine, M.S.3
-
8
-
-
0037188605
-
Elevated C-reactive protein in patients with obstructive sleep apnea
-
DOI 10.1161/01.CIR.0000018948.95175.03
-
Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 2002;105(21):2462-2464. (Pubitemid 34568964)
-
(2002)
Circulation
, vol.105
, Issue.21
, pp. 2462-2464
-
-
Shamsuzzaman, A.S.M.1
Winnicki, M.2
Lanfranchi, P.3
Wolk, R.4
Kara, T.5
Accurso, V.6
Somers, V.K.7
-
9
-
-
4644288261
-
The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome
-
DOI 10.1016/j.cyto.2004.07.003, PII S1043466604002170
-
Ciftci TU, Kokturk O, Bukan N, Bilgihan A. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine. 2004;28(2):87-91. (Pubitemid 39302489)
-
(2004)
Cytokine
, vol.28
, Issue.2
, pp. 87-91
-
-
Ciftci, T.U.1
Kokturk, O.2
Bukan, N.3
Bilgihan, A.4
-
10
-
-
67650828305
-
Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea
-
Ishida K, Kato M, Kato Y, et al. Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea. Chest. 2009; 136(1):125-129.
-
(2009)
Chest
, vol.136
, Issue.1
, pp. 125-129
-
-
Ishida, K.1
Kato, M.2
Kato, Y.3
-
11
-
-
79551585992
-
Cysteine: A potential biomarker for obstructive sleep apnea
-
Cintra F, Tufik S, D'Almeida V, et al. Cysteine: a potential biomarker for obstructive sleep apnea. Chest. 2011;139(2): 246-252.
-
(2011)
Chest
, vol.139
, Issue.2
, pp. 246-252
-
-
Cintra, F.1
Tufik, S.2
D'Almeida, V.3
|